Cite
Next-generation sequencing demonstrates genomic signature of resistance patterns following phosphatidylinositol 3-kinase (PI3K) inhibition.
MLA
Rauh-Hain, Alejandro, et al. “Next-Generation Sequencing Demonstrates Genomic Signature of Resistance Patterns Following Phosphatidylinositol 3-Kinase (PI3K) Inhibition.” Gynecologic Oncology, vol. 136, no. 2, Feb. 2015, p. 406. EBSCOhost, https://doi.org/10.1016/j.ygyno.2014.11.056.
APA
Rauh-Hain, A., Minji Kim, Ling Zhang, Foster, R., Rueda, B., Bhasin, M. K., & Growdon, W. (2015). Next-generation sequencing demonstrates genomic signature of resistance patterns following phosphatidylinositol 3-kinase (PI3K) inhibition. Gynecologic Oncology, 136(2), 406. https://doi.org/10.1016/j.ygyno.2014.11.056
Chicago
Rauh-Hain, Alejandro, Minji Kim, Ling Zhang, Rosemary Foster, Bo Rueda, Manoj K. Bhasin, and Whitfield Growdon. 2015. “Next-Generation Sequencing Demonstrates Genomic Signature of Resistance Patterns Following Phosphatidylinositol 3-Kinase (PI3K) Inhibition.” Gynecologic Oncology 136 (2): 406. doi:10.1016/j.ygyno.2014.11.056.